A trial of prophylactic replacement therapy in haemophilia and Christmas disease
AUTOR(ES)
Ramsay, D. M.
RESUMO
A trial of prophylactic replacement therapy in low dosage once a week is described in two patients with classical haemophilia and one patient with Christmas disease, using concentrates of factor VIII and factor IX respectively. The clinical effectiveness and complications of the therapy are assessed and discussed. It was concluded that the patient suffering from Christmas disease showed both objective and subjective improvement while on prophylaxis and merited further study. Neither of the patients with haemophilia showed objective evidence of improvement, but both stated that they felt fitter and more able to lead a normal life while on the trial.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=477696Documentos Relacionados
- Twice weekly prophylactic therapy in haemophilia A.
- DIAGNOSTIC DIFFICULTIES IN MILD HAEMOPHILIA AND CHRISTMAS DISEASE
- Serum enzyme changes after intramuscular bleeding in patients with haemophilia and Christmas disease
- Enzyme replacement therapy in Gaucher's disease: preliminary clinical trial of a new enzyme preparation.
- Partial thromboplastin time test with kaolin: diagnosis of haemophilia and Christmas disease without natural reference plasmas